Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Advisors Llc Orbimed currently holds 1,348,825 shares of Anthera Pharmaceuticals Inc (ANTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Advisors Llc Orbimed has been a net seller of ANTH stock. They have purchased $441.8M and sold $596.1M worth of shares.
Advisors Llc Orbimed's most recent insider trade was on Jul 27, 2026, when they sold 2,065,672 shares at $0.00 per share.
Advisors Llc Orbimed serves as Executive at Anthera Pharmaceuticals Inc (ANTH). They have executed 502 insider transactions totaling $1.0B over their tenure at the company.
Advisors Llc Orbimed holds the position of Executive at Anthera Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Advisors Llc Orbimed has shown a selling trading pattern, with $441.8M in total purchases and $596.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Advisors Llc Orbimed was on Jul 27, 2026, when they purchased $15.0M worth of SCTX shares. This transaction involved 1,000,000 shares at $15.00 per share.
Advisors Llc Orbimed currently owns 1,348,825 shares of Anthera Pharmaceuticals Inc (ANTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Advisors Llc Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Advisors Llc Orbimed has 502 Form 4 filings on record as an insider at Anthera Pharmaceuticals Inc.
Set alerts for Advisors Llc Orbimed and 40,000+ other insiders.